Valuation: Revvity, Inc.

Capitalization 11.86B 10.13B 9.46B 8.75B 16.23B 1,018B 18.19B 113B 43.01B 475B 44.5B 43.58B 1,742B P/E ratio 2025 *
41x
P/E ratio 2026 * 32.4x
Enterprise value 13.63B 11.64B 10.87B 10.05B 18.66B 1,170B 20.9B 130B 49.43B 546B 51.13B 50.08B 2,002B EV / Sales 2025 *
4.78x
EV / Sales 2026 * 4.37x
Free-Float
99.71%
Yield 2025 *
0.28%
Yield 2026 * 0.27%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.98%
1 week+1.65%
Current month+4.07%
1 month+9.45%
3 months+9.66%
6 months-13.54%
Current year-9.81%
More quotes
1 week 97.96
Extreme 97.96
102.34
1 month 92.78
Extreme 92.78
102.34
Current year 87.7
Extreme 87.7
128.28
1 year 87.7
Extreme 87.7
129.5
3 years 79.5
Extreme 79.5
170
5 years 79.5
Extreme 79.5
203.16
10 years 39.5
Extreme 39.5
203.16
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 29/12/2019
Director of Finance/CFO 36 05/09/2022
Chief Tech/Sci/R&D Officer - 30/04/2023
Director TitleAgeSince
Chairman 67 29/12/2019
Director/Board Member 72 06/02/2012
Director/Board Member 71 26/07/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.98%+1.65%-3.80%-31.06% 11.63B
-1.39%-1.99%+18.62%+152.53% 192B
+1.78%+1.12%-20.53%-23.03% 158B
-1.37%-2.26%+34.56%+170.64% 154B
+0.53%-0.21%-16.61%-23.92% 143B
+0.67%-0.32%-12.32%-3.04% 60.95B
-0.39%-1.02%-16.82%-22.36% 44.99B
+0.07%+0.13%+33.00%+17.88% 37.53B
+0.43%-3.30%-23.99%-31.18% 36.48B
+0.79%-0.99%-1.51% - 34.16B
Average +0.31%-0.49%-0.94%+22.94% 87.19B
Weighted average by Cap. -0.03%-0.49%+2.31%+55.35%
See all sector performances

Financials

2025 *2026 *
Net sales 2.85B 2.44B 2.27B 2.1B 3.9B 245B 4.37B 27.26B 10.35B 114B 10.7B 10.48B 419B 3.03B 2.59B 2.41B 2.23B 4.14B 260B 4.64B 28.91B 10.97B 121B 11.35B 11.12B 444B
Net income 282M 241M 225M 208M 386M 24.2B 432M 2.69B 1.02B 11.29B 1.06B 1.04B 41.41B 363M 310M 289M 268M 496M 31.13B 556M 3.47B 1.32B 14.52B 1.36B 1.33B 53.27B
Net Debt 1.77B 1.51B 1.41B 1.3B 2.42B 152B 2.71B 16.9B 6.41B 70.8B 6.63B 6.5B 260B 1.36B 1.16B 1.08B 1B 1.86B 117B 2.09B 13B 4.93B 54.47B 5.1B 5B 200B
More financial data * Estimated data
Logo Revvity, Inc.
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Employees
11,000
Calendar
More about the company
Date Price Change Volume
08/07/25 100.66 $ +1.98% 930,087
07/07/25 98.71 $ -2.57% 1,004,981
03/07/25 101.31 $ +0.41% 811,002
02/07/25 100.90 $ +1.89% 967,923
01/07/25 99.03 $ +2.39% 866,102

Delayed Quote Nyse, July 08, 2025 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
100.66USD
Average target price
124.12USD
Spread / Average Target
+23.31%
Consensus

Quarterly revenue - Rate of surprise